• A Piccioni, M Brigida, V Loria, C Zanza, Y Longhitano, R Zaccaria, S Racco, A Gasbarrini, V Ojetti, F Franceschi, and M Candelli.
• Emergency Department Fondazione Policlinico Universitario A. Gemelli, IRCSS, Rome, Italy. andrea.piccioni@unicatt.it.
• Eur Rev Med Pharmacol Sci. 2020 Oct 1; 24 (19): 10293-10300.

AbstractAcute SARS-CoV-2 respiratory disease is an infectious respiratory disease caused by the virus SARS-CoV-2 belonging to the coronaviridae family. A pandemic is still present as of May 2020. In addition to causing pneumonia, SARS-CoV-2 may induce a direct damage to the heart, causing myocarditis, with significant impairment of cardiac contractility, and/or pericarditis. Elderly patients and those with cardiovascular risk factors, such as hypertension and diabetes mellitus, are at increased risk of heart complications from COVID-19. In this review, we focused on the correlation between COVID-19 infection and the high sensitivity troponin T and I, and their significance in the development of myocarditis. Data emerging from the studies so far conducted indicate that a high value of high-sensitivity troponin represents a negative prognostic indicator when associated with heart damage on an infectious-inflammatory basis (i.e. myopericarditis). We should identify a safe and clear diagnostic algorithm, possibly combining patient clinical history, troponin levels and cardiac ultrasound findings that could help us in the prediction of myopericarditis.

16 keywords...

hide…